Covered recipient · General Payments record
REBECCA MARTISEK
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,632.72
- Reported across 200 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $295.75 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $134.71 | 8 |
| BOSTON SCIENTIFIC CORPORATION | $35.39 | 2 |
| Teva Pharmaceuticals USA, Inc. | $28.34 | 1 |
| ACADIA Pharmaceuticals Inc | $24.67 | 1 |
| Amneal Pharmaceuticals LLC | $22.45 | 1 |
| Life Molecular Imaging Ltd | $20.29 | 1 |
| PFIZER INC. | $15.50 | 1 |
| Celgene Corporation | $14.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.18 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600807 | CMS |
| ABBVIE INC. | $19.53 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600809 | CMS |
| ABBVIE INC. | $28.03 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600811 | CMS |
| ABBVIE INC. | $9.23 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600813 | CMS |
| ABBVIE INC. | $21.55 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600815 | CMS |
| ABBVIE INC. | $21.11 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600817 | CMS |
| ABBVIE INC. | $12.39 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600819 | CMS |
| ABBVIE INC. | $12.69 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600821 | CMS |
| ACADIA Pharmaceuticals Inc | $24.67 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148008875 | CMS |
| Amneal Pharmaceuticals LLC | $22.45 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139213466 | CMS |
| Boston Scientific Corporation | $14.52 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092604582 | CMS |
| Boston Scientific Corporation | $20.87 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092604584 | CMS |
| Celgene Corporation | $14.40 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101096742 | CMS |
| Life Molecular Imaging Ltd | $20.29 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154808982 | CMS |
| PFIZER INC. | $15.50 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131122314 | CMS |
| Teva Pharmaceuticals USA, Inc. | $28.34 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151667493 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.